Business Development: Licensing Partners

Partnerships are crucial to our success. We can’t do it alone, which is why we choose to partner with those with similar goals in mind. Working with both domestic and international companies allows us to bring a wider range of products to market that wouldn’t be possible before. This allows for greater options for patients, consumers, pharmacists, physicians, and other healthcare professionals.

Upsher-Smith’s wholly owned subsidiary, Proximagen Limited, is a European biotechnology company that focuses on therapeutics for the central nervous system (CNS). Proximagen Limited provides a platform for product development in CNS, inflammation, oncology, and obesity to expand our pipeline even further.

With a wide distribution network, an experienced commercial team, and well-established customer relationships, Upsher-Smith is well positioned to grow with the right companies. Looking ahead, we are focused on the following areas:

  • CNS
  • Generic Products

For more information, please contact Corporate Development at uslcorpdev@upsher-smith.com. Or via:

Upsher-Smith Laboratories, Inc.
6701 Evenstad Drive
Maple Grove, MN 55369